HLA
ETRM

Hamilton Lane Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Hamilton Lane Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-106
Closed -$136K – 76
2014
Q3 		$136K Buy
+106
New +$155K 0.04% 52

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Hamilton Lane Advisors's ETRM Position: Q4 2014 in Review

Hamilton Lane Advisors sold out of EnteroMedics Inc. (ETRM) in Q4 2014, closing a stake of 106 shares — an estimated $136K sold.

Hamilton Lane Advisors first reported a position in ETRM in Q3 2014 and held it in 1 quarter. The position peaked at $136K in Q3 2014. 46 funds tracked by Wall St. Rank hold ETRM as of Q4 2014.

  • Hamilton Lane Advisors reported no remaining EnteroMedics Inc. position as of Q4 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 106 EnteroMedics Inc. shares in Q4 2014, an estimated $136K.
  • Hamilton Lane Advisors first reported a position in EnteroMedics Inc. in Q3 2014 and held it in 1 quarter.
  • Hamilton Lane Advisors's EnteroMedics Inc. position peaked at $136K in Q3 2014.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2014.

Based on Hamilton Lane Advisors's 13F filing for Q4 2014, filed 26 Jan 2015.